Eugene M. McKelvey
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Immunology top 5%
- Genetics top 2%
- Molecular Biology
- Co-authors
- John L. FaheyStephen E. JonesJ. L. FaheyRobert W. TalleyThomas E. MoonMontague LaneHenry E. WilsonP Grozea
- Topics
- Lymphoma Diagnosis and Treatment (5 papers)Blood properties and coagulation (3 papers)Platelet Disorders and Treatments (3 papers)
- Partner nations
- United StatesMalaysia
In The Last Decade
Eugene M. McKelvey
24 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Pathology and Forensic Medicine 820
- Oncology 553
- Immunology 551
- Genetics 448
- Molecular Biology 396
Countries citing papers authored by Eugene M. McKelvey
This map shows the geographic impact of Eugene M. McKelvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene M. McKelvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene M. McKelvey more than expected).
Fields of papers citing papers by Eugene M. McKelvey
This network shows the impact of papers produced by Eugene M. McKelvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene M. McKelvey. The network helps show where Eugene M. McKelvey may publish in the future.
Co-authorship network of co-authors of Eugene M. McKelvey
This figure shows the co-authorship network connecting the top 25 collaborators of Eugene M. McKelvey. A scholar is included among the top collaborators of Eugene M. McKelvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene M. McKelvey. Eugene M. McKelvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study. | 4 |
| 2 | Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. | 49 |
| 3 | 2 | |
| 4 | 36 | |
| 5 | 185 | |
| 6 | 11 | |
| 7 | 12 | |
| 8 | 28 | |
| 9 | Combination chemotherapy (CHOP BLEO) of advanced diffuse histiocytic lymphoma (DHL) | 2 |
| 10 | Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomabreakdown → | 625 |
| 11 | Reduction of ifosfamide toxicity using dose fractionation. | 40 |
| 12 | 17 | |
| 13 | 26 | |
| 14 | 1 | |
| 15 | 38 | |
| 16 | 4 | |
| 17 | Quantitative Determination of Serum Immunoglobulins in Antibody-Agar Platesbreakdown → | 1380 |
| 18 | 23 | |
| 19 | 144 | |
| 20 | 15 |
About Eugene M. McKelvey
Eugene M. McKelvey is a scholar working on Hematology, Pathology and Forensic Medicine and Dermatology, having authored 25 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Blood properties and coagulation (3 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (820 citations), Genetics (448 citations) and Hematology (353 citations). Eugene M. McKelvey has collaborated with scholars based in United States and Malaysia. Frequent co-authors include John L. Fahey, Stephen E. Jones, J. L. Fahey, Robert W. Talley, Thomas E. Moon, Montague Lane, Henry E. Wilson, P Grozea, Arthur Haut and Charles A. Coltman. Their work appears in journals such as Journal of Clinical Investigation, Blood and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.